Ketesse injection
Marketed by Ferron Par Pharmaceuticals
Ingredients in every ml
| Dexketoprofen | 25 mg |
Each package contains
5 ampoules of 2 ml
Dosage form
 |
injection |
Dosage formInjection
Flavour
None
W.H.O. classification
N02B
N02B
A.T.C. Level 1
Anatomical Main group
N - Nervous system
N02B
A.T.C. Level 2
Therapeutic subgroup
N02 - Analgesics
N02B
A.T.C. Level 3
Pharmacological subgroup
N02B - Other Analgesics and Antipyretics in ATC
Available in
 |
Indonesia |
Warnings
Alcohol
CAUTIONThis item may not be safe for use with alcohol. Use with caution and after consultation with your doctor.
Machinery
NOT RECOMMENDEDThis item should not be used while operating heavy machinery.
Pregnancy
NOT RECOMMENDEDThis item is not safe for use during pregnancy.
Lactation
NOT RECOMMENDEDThis item is not safe for use during lactation.
Indication
Pain symptoms of acute intensity
Symptomatic treatment of acute pain when oral administration is not appropriate, such as postoperative pain. (IPHA p.2, Medscape p.1, PI Ketesse, Product Monograph-2 p.70, Product Profile Injection p.89, SPC p.1)
Symptomatic treatment of acute pain when oral administration is not appropriate, such as postoperative pain. (IPHA p.2, Medscape p.1, PI Ketesse, Product Monograph-2 p.70, Product Profile Injection p.89, SPC p.1)
Dosage
UP TO 18 YEARS
The safety and efficacy Ketesse in children have not been established and the product should not be used in children.
Ketesse® is not for long period usage, and the therapy should be limited for acute symptomatic period
18 YEARS OLD AND ABOVE
The recommended dose is 50 mg every 8-12 hours. Repeated every 6 hours if necessary. Total daily dose should not exceed 150 mg.
Ketesse® is not for long period usage, and the therapy should be limited for acute symptomatic period
POSTOPERATIVE PAIN
Ketesse® can be used with opioid analgesic to overcome the pain, especially in the initial period after surgery when the pain is more painful.
The safety and efficacy Ketesse in children have not been established and the product should not be used in children.
Ketesse® is not for long period usage, and the therapy should be limited for acute symptomatic period
18 YEARS OLD AND ABOVE
The recommended dose is 50 mg every 8-12 hours. Repeated every 6 hours if necessary. Total daily dose should not exceed 150 mg.
Ketesse® is not for long period usage, and the therapy should be limited for acute symptomatic period
POSTOPERATIVE PAIN
Ketesse® can be used with opioid analgesic to overcome the pain, especially in the initial period after surgery when the pain is more painful.